“About 25 percent of patients with low back pain actually suffer from SI joint dysfunction,” said Michael Oh, MD, chief of the division of functional neurosurgery at Allegheny General Hospital. “While it’s difficult to diagnose, once it’s identified, it can generally be treated very successfully.”
Dr. Oh was a principal investigator of a clinical trial at Allegheny General Hospital comparing patients who undergo surgical treatment with iFuse to those who rely on conservative care.
More articles on spine orthopedic devices:
Medtronic CEO sells 20k shares for $1.52M: 5 key points
OsteoRemedies appoints Eric Stookey COO
DOJ extends Biomet’s deferred prosecution agreement
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.